Contacts

Howard Palmer

Partner

Read More

Harry Ruffell

Associate

Read More
Contacts

Howard Palmer

Partner

Read More

Harry Ruffell

Associate

Read More

3 February 2021

Vortexa completes US$19m Series B funding round

We have advised long-standing client Vortexa on a USD$19 million Series B funding round.

Vortexa is an energy intelligence provider that combines AI and deep industry expertise to deliver the most complete real-time data and analytics tools for waterborne energy and shipping markets.

The round was led by monashees with participation from all existing investors, including Notion Capital, Mosaic Ventures and Metaplanet Holdings. The investment brings the total amount raised by Vortexa to more than USD$30 million. 

Vortexa will use the funding to further accelerate its international expansion and technology development.

Commenting on the deal, Corporate Technology Partner Howard Palmer, said: "This deal will allow Vortexa to scale its Global Energy Analytics Platform, accelerating its exceptional growth. We look forward to more collaboration in the future as Vortexa enters the next phase of its corporate journey."

Fabio Kuhn, Founder & CEO of Vortexa, said: "The venture market continues to grow in the UK, and this funding is unlocking immense value for our clients, partners and society. The Taylor Wessing team continues to support Vortexa with strategic, legal advice and in-depth market knowledge."

The team was led by Corporate Technology Partner Howard Palmer, with support from Associates Alex Dodds and Harry Ruffell, and Paralegal Sarah Palmer, with support from Wilson Sonsini Goodrich & Rosati in respect of US matters.  

 
Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

Corporate/M&A & capital markets

Advising GeoPura on its £56 million investment round to accelerate UK's green hydrogen expansion

22 February 2024

by multiple authors

Click here to find out more
Corporate/M&A & capital markets

Advising Vortexa on its $34 million Series C funding

9 January 2024

by multiple authors

Click here to find out more
Corporate/M&A & capital markets

Apollo Therapeutics closes $226.5 million series C financing

7 September 2023

by multiple authors

Click here to find out more